CN Stock MarketDetailed Quotes
300158 Shanxi Zhendong Pharmaceutical
- 4.04
- -0.04-0.98%
Market Closed Jun 14 15:00 CST
4.15BMarket Cap-202000P/E (TTM)
4.10High4.00Low193.93KlotVolume4.07Open4.08Pre Close78.40MTurnover1.90%Turnover RatioLossP/E (Static)1.03BShares8.4752wk High0.81P/B4.14BFloat Cap3.6252wk Low4.90Limit Up1.02BShs Float12.96Historical High3.26Limit Down2.45%Amplitude0.48Historical Low--Dividend TTM4.04Avg Price95.04KlotAsk--Div YieldTTM100Lot Size98.11KlotBid
Shanxi Zhendong Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -15.20%652.19M | 11.19%800.88M | -20.27%974.68M | -37.75%885.24M | -0.33%769.05M | -41.06%720.27M | 91.78%1.22B | 107.76%1.42B | 73.71%771.63M | 31.91%1.22B |
| Transactional financial assets | -14.02%1.41B | -28.29%1.45B | -8.69%1.32B | -5.98%1.55B | -66.98%1.64B | -54.82%2.02B | --1.44B | --1.64B | --4.98B | --4.47B |
| Notes receivable and accounts receivable | -16.55%713.67M | -7.07%752.05M | -8.59%778.48M | -5.36%795.01M | -7.24%855.25M | -14.41%809.3M | -26.74%851.67M | -36.94%840.07M | -36.19%922.03M | -23.87%945.55M |
| -Notes receivable | -55.15%68.4M | 22.14%127.12M | 95.84%132.58M | 96.21%157.13M | 100.13%152.51M | 57.33%104.08M | -31.13%67.7M | -46.61%80.08M | -44.42%76.2M | -38.81%66.15M |
| -Accounts receivable | -8.18%645.27M | -11.39%624.93M | -17.61%645.9M | -16.07%637.89M | -16.92%702.74M | -19.81%705.22M | -26.33%783.97M | -35.72%759.99M | -35.33%845.83M | -22.45%879.4M |
| Other receivables (including interest and dividends) | -18.37%73.18M | -22.17%44.71M | -85.30%54.53M | -86.56%48.81M | -83.02%89.64M | -88.57%57.44M | 145.94%371.02M | 182.79%363.12M | 315.35%527.94M | 414.79%502.55M |
| -Other receivable | ---- | ---- | ---- | -86.56%48.81M | ---- | -88.57%57.44M | ---- | 182.79%363.12M | ---- | 414.79%502.55M |
| Advance payment | -4.22%106.33M | -46.80%99.6M | -43.55%148.45M | -36.66%138.21M | -53.87%111.01M | -40.09%187.22M | -33.38%262.97M | -46.27%218.21M | -38.12%240.68M | 12.45%312.53M |
| Inventories | -11.68%1.13B | 11.26%1.2B | 6.61%1.21B | 3.35%1.13B | 31.19%1.28B | 14.65%1.07B | 21.39%1.14B | 17.74%1.1B | 2.89%975.69M | 13.58%937.14M |
| Receivable financing | --87.21M | --104M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | -0.53%11.92M | 2.28%15.66M | -13.73%8.27M | -25.04%9.7M | -58.64%11.99M | -55.11%15.31M | -90.09%9.58M | -82.11%12.94M | -60.17%28.98M | -30.87%34.1M |
| Total current assets | -12.02%4.19B | -8.66%4.46B | -15.16%4.5B | -18.60%4.56B | -43.64%4.76B | -42.03%4.88B | -12.09%5.3B | 57.42%5.6B | 121.38%8.45B | 120.55%8.42B |
| Non Current assets | ||||||||||
| Other equity investment | 27.32%87.02M | -2.27%57.02M | -36.58%36.94M | -36.58%36.94M | 17.22%68.34M | 0.07%58.34M | 0.67%58.25M | 4.27%58.25M | 4.36%58.3M | 4.36%58.3M |
| Investment real estate | --14.87M | --15.65M | --15.85M | --16.05M | ---- | ---- | ---- | ---- | ---- | ---- |
| Long term receivable account | ---- | ---- | ---- | ---- | -89.24%116.13K | -89.55%116.13K | -47.80%579.88K | -47.80%579.88K | -57.05%1.08M | -55.80%1.11M |
| Fixed assets | ---- | ---- | ---- | -5.31%941.89M | ---- | -3.95%983.69M | ---- | -4.11%994.69M | ---- | 9.85%1.02B |
| Constru in process | ---- | ---- | ---- | -3.38%33.6M | ---- | 11.80%22.24M | ---- | 5.61%34.77M | ---- | 108.03%19.89M |
| Construction materials | ---- | ---- | ---- | --2.24M | ---- | --1.97M | ---- | ---- | ---- | ---- |
| Productive biological assets | -11.11%987.23K | -14.29%987.23K | -10.34%1.07M | -13.33%1.07M | -14.74%1.11M | -12.50%1.15M | -9.37%1.19M | -6.25%1.23M | -12.04%1.3M | -11.11%1.32M |
| Intangible assets | -3.49%250.94M | 0.65%260.07M | -0.69%255.86M | -2.21%255.87M | 5.34%260.01M | 3.20%258.39M | 1.45%257.64M | -0.95%261.65M | 26.89%246.83M | 25.50%250.37M |
| Development expenditure | -0.71%194.45M | 0.85%194.43M | 8.75%200.83M | 9.92%198.2M | 2.57%195.83M | 1.88%192.79M | -1.91%184.67M | 2.55%180.31M | 14.54%190.93M | 16.07%189.23M |
| Goodwill | 0.00%40.24M | 0.00%40.24M | 0.00%40.24M | 0.00%40.24M | 0.00%40.24M | 0.00%40.24M | -1.20%40.24M | -98.28%40.24M | -98.28%40.24M | -98.28%40.24M |
| Long deferred expense | -40.18%5.48M | -28.11%5.95M | -61.69%5.22M | -39.73%6.84M | 43.11%9.16M | 32.04%8.27M | 73.62%13.63M | -8.43%11.35M | -54.77%6.4M | -59.45%6.26M |
| Deferred tax assets | 14.30%21.16M | 11.34%21.01M | 1.13%19.81M | -10.04%19.99M | -19.93%18.51M | -20.82%18.87M | -14.73%19.59M | -19.55%22.22M | -20.34%23.12M | -18.20%23.83M |
| Usufruct assets | -1.00%2.51M | 102.59%2.36M | 98.01%2.6M | 86.45%2.84M | 41.09%2.54M | -39.38%1.16M | 134.98%1.31M | -90.06%1.52M | -45.12%1.8M | -88.16%1.92M |
| Other non current assets | 136.94%196.32M | 62.86%130.95M | 37.44%90.08M | 118.46%88.57M | 91.98%82.86M | 51.11%80.41M | 17.45%65.54M | 23.88%40.54M | 22.32%43.16M | 50.81%53.21M |
| Total non current assets | 7.54%1.8B | 3.15%1.72B | -0.74%1.64B | -0.18%1.64B | 0.83%1.67B | -0.13%1.67B | -0.47%1.66B | -58.82%1.65B | -56.19%1.66B | -56.01%1.67B |
| Total assets | -6.94%5.98B | -5.65%6.18B | -11.73%6.14B | -14.41%6.2B | -36.35%6.43B | -35.10%6.55B | -9.58%6.96B | -4.12%7.24B | 33.03%10.1B | 32.55%10.09B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -99.51%97.8K | -99.52%97.8K | ---- | ---- | -90.46%20.02M | -90.28%20.48M | -83.78%73M | -42.00%223.27M | -20.51%209.86M | -48.98%210.77M |
| Notes payable and accounts payable | -40.03%336.89M | -17.14%418M | -24.83%450.75M | -17.49%491.08M | -14.72%561.8M | -13.75%504.48M | 18.16%599.62M | 49.51%595.16M | 44.00%658.78M | 102.18%584.92M |
| -Notes payable | 6.85%40.95M | 11.13%37.98M | 40.91%36.52M | 59.23%37.74M | 130.00%38.32M | 372.72%34.18M | 1,561.50%25.92M | 25.41%23.7M | --16.66M | --7.23M |
| -Accounts payable | -43.46%295.95M | -19.20%380.01M | -27.80%414.23M | -20.67%453.33M | -18.48%523.47M | -18.59%470.31M | 13.40%573.7M | 50.71%571.46M | 40.36%642.12M | 99.68%577.69M |
| Contract liabilities | -9.08%80.03M | -53.64%68.42M | -0.06%61.92M | 37.48%86.76M | 28.44%88.02M | 70.44%147.59M | -25.70%61.96M | -13.64%63.11M | -30.38%68.53M | -19.93%86.59M |
| Salaries payable | 7.09%27.45M | 11.40%32.2M | 9.27%27.25M | -12.75%21.71M | -0.57%25.63M | 3.41%28.91M | 2.07%24.94M | -17.53%24.89M | -26.07%25.78M | -21.19%27.95M |
| Taxs payable | -18.03%30.68M | -58.95%22.75M | -53.34%37.44M | -73.18%45.91M | -91.96%37.43M | -88.15%55.42M | 26.07%80.23M | 122.78%171.17M | 854.73%465.52M | 562.42%467.77M |
| Other payable (including interest and dividends) | -20.34%271.88M | -34.13%285.53M | -64.17%242.73M | -65.62%215.29M | -8.05%341.31M | 7.29%433.46M | 26.80%677.48M | 0.76%626.28M | -36.01%371.18M | -32.17%404M |
| -Other payable | ---- | ---- | ---- | -65.62%215.29M | ---- | 7.29%433.46M | ---- | 0.76%626.28M | ---- | -32.17%404M |
| Non current liabilities due within one year | 291.57%1.23M | 289.46%1.22M | 67.93%806.57K | 50.25%806.57K | -43.39%314.32K | -56.75%314.32K | --480.32K | --536.83K | -62.98%555.28K | -62.64%726.77K |
| Other current liabilities | 134.82%35.83M | 375.65%88.85M | 8.40%15.63M | 11.88%17.07M | -0.85%15.26M | 7.60%18.68M | 100.51%14.42M | -7.37%15.26M | 4.65%15.39M | 23.47%17.36M |
| Total current liabilities | -28.05%784.1M | -24.17%917.07M | -45.40%836.53M | -48.91%878.62M | -39.98%1.09B | -32.82%1.21B | -14.78%1.53B | 7.40%1.72B | 8.15%1.82B | 5.38%1.8B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --97M | --100.14M | --100.14M |
| Long term account payable | ---- | ---- | ---- | 0.00%74.67M | ---- | -7.04%74.67M | ---- | -31.50%74.67M | ---- | -55.69%80.32M |
| Specific account payable | ---- | ---- | ---- | 27.10%1.25M | ---- | -94.92%50K | ---- | 0.00%983.5K | ---- | -50.42%983.5K |
| Deferred tax liabilities | --296.84K | --296.84K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Long term deferred income | -0.15%42.41M | 0.65%42.77M | -14.20%39.58M | -15.18%40.42M | -10.82%42.47M | -24.63%42.49M | -9.43%46.13M | -17.05%47.65M | -35.72%47.63M | -27.68%56.38M |
| Lease liabilities | -44.05%985.33K | 41.76%1.53M | 99.22%1.92M | 129.08%1.88M | 40.07%1.76M | 0.06%1.08M | 102.56%962.06K | -96.08%820.89K | --1.26M | -94.57%1.08M |
| Total non current liabilities | -0.67%118.16M | 0.86%119.31M | -4.44%116.4M | -46.54%118.22M | -47.38%118.95M | -50.49%118.29M | -10.76%121.8M | 16.82%221.12M | 20.01%226.06M | -15.34%238.9M |
| Total liabilities | -25.35%902.26M | -21.94%1.04B | -42.38%952.93M | -48.64%996.84M | -40.80%1.21B | -34.89%1.33B | -14.50%1.65B | 8.40%1.94B | 9.35%2.04B | 2.44%2.04B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.03B | 0.00%1.03B | 0.00%1.03B | 0.00%1.03B | 0.00%1.03B | 0.00%1.03B | 0.00%1.03B | 0.00%1.03B | 0.00%1.03B | 0.00%1.03B |
| Capital reserve funds | 0.00%3.76B | 0.00%3.76B | 0.00%3.76B | 0.00%3.76B | 0.00%3.76B | 0.00%3.76B | 0.00%3.76B | 0.00%3.76B | 0.00%3.76B | 0.00%3.76B |
| Surplus reserve funds | 0.00%481.35M | 0.00%481.35M | 0.00%481.35M | 0.00%481.35M | 0.00%481.35M | 0.00%481.35M | 346.67%481.35M | 346.67%481.35M | 346.67%481.35M | 346.67%481.35M |
| Retained profit | -128.04%-36.49M | -281.84%-59.59M | -127.27%-16.48M | -101.76%-1.06M | -100.57%-16M | -100.56%-15.61M | -93.20%60.43M | -93.22%60.33M | 232.91%2.82B | 279.34%2.81B |
| Less:Treasury stock | --84.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other composite income | -2,262.89%-32.71M | -2,244.96%-32.71M | -25,369.91%-32.74M | -6,278.55%-32.73M | 5.74%-1.38M | 5.05%-1.39M | 93.21%-128.53K | 72.91%-513.14K | 23.58%-1.47M | 22.44%-1.47M |
| Shareholders equity without minority interests | -2.59%5.12B | -1.43%5.18B | -2.05%5.22B | -1.76%5.24B | -35.05%5.25B | -34.97%5.25B | -7.84%5.33B | -7.85%5.33B | 40.86%8.09B | 43.35%8.08B |
| Minority interests | -13.17%-35.5M | -12.59%-34.75M | -17.65%-34.12M | -23.52%-33.2M | -18.43%-31.37M | -22.70%-30.86M | -11.09%-29M | -35.92%-26.87M | -85.74%-26.49M | -115.15%-25.15M |
| Total shareholder equity | -2.68%5.08B | -1.52%5.14B | -2.16%5.19B | -1.88%5.2B | -35.22%5.22B | -35.15%5.22B | -7.92%5.3B | -8.00%5.3B | 40.75%8.06B | 43.20%8.05B |
| Total liabilityies and equity | -6.94%5.98B | -5.65%6.18B | -11.73%6.14B | -14.41%6.2B | -36.35%6.43B | -35.10%6.55B | -9.58%6.96B | -4.12%7.24B | 33.03%10.1B | 32.55%10.09B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | CITIC Certified Public Accountants (Special General Partnership) | -- | -- | -- | CITIC Certified Public Accountants (Special General Partnership) | -- | -- | -- | CITIC Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg